BIOMAT Database Logo BIOMAT Database Logo

[Minimal inhibitory concentration in hospital bacteria]. 1974

F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009268 Nalidixic Acid A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. Nalidixin,Nalidixate Sodium,Nalidixate Sodium Anhydrous,Nevigramon,Sodium Nalidixic Acid, Anhydrous,Sodium Nalidixic Acid, Monohydrate,Acid, Nalidixic,Anhydrous, Nalidixate Sodium,Sodium Anhydrous, Nalidixate,Sodium, Nalidixate
D009581 Nitrofurans Compounds containing FURANS attached to a nitro group.
D010093 Oxolinic Acid Synthetic antimicrobial related to NALIDIXIC ACID and used in URINARY TRACT INFECTIONS. Gramurin,Sodium Oxolinate,Acid, Oxolinic,Oxolinate, Sodium
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
Wild-type minimal inhibitory concentration distributions in bacteria of animal origin in Argentina.
January 2014, Revista Argentina de microbiologia,
F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
[In vitro investigations of rifampicin. Correlation between minimal inhibitory concentration and minimal inhibitory zone].
January 1978, Arzneimittel-Forschung,
F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
Study of minimal inhibitory concentration of antibiotics on bacteria cultivated in vitro in space (Cytos 2 experiment).
August 1985, Aviation, space, and environmental medicine,
F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
Range of antibacterial activity of antibiotics at subminimal inhibitory concentrations: the ratio of minimal inhibitory concentration to minimal antibiotic concentration.
January 1979, Reviews of infectious diseases,
F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
[Minimal inhibitory concentration of antibiotics in the amniotic fluid].
November 1975, Archiv fur Gynakologie,
F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
Testing physiologically relevant conditions in minimal inhibitory concentration assays.
August 2021, Nature protocols,
F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria.
December 1998, Planta medica,
F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.
November 1975, Antimicrobial agents and chemotherapy,
F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
[Determination of antibiotic minimal inhibitory concentration using a micromethod].
November 1972, Pathologie-biologie,
F M Marcenac, and A J Fernández, and M N Rebollo, and H T Helou, and T R Civalero, and I L Herran, and M A Magri
Interactions between antibacterial drugs below the minimal inhibitory concentration.
January 1979, Reviews of infectious diseases,
Copied contents to your clipboard!